Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar;182(6):1292-1305.
doi: 10.1111/bph.17406. Epub 2024 Dec 2.

Synergistic-like decreases in alcohol intake following combined pharmacotherapy with GLP-1 and amylin in male rats

Cajsa Aranäs  1 , Antonia Caffrey  2   3 , Christian E Edvardsson  1 , Jesper Vestlund  1 , Heath D Schmidt  2   3 , Elisabet Jerlhag  1
Affiliations

Synergistic-like decreases in alcohol intake following combined pharmacotherapy with GLP-1 and amylin in male rats

Cajsa Aranäs et al. Br J Pharmacol. 2025 Mar.

Abstract

Background and purpose: The limited effectiveness of current pharmacological treatments for alcohol use disorder (AUD) highlights the need for novel therapies. These may involve the glucagon-like peptide-1 receptor or the amylin receptor, as treatment with agonists targeting either of these receptors lowers alcohol intake. The complexity of the mechanisms underlying AUD indicates that combining agents could enhance treatment efficacy. While a combination of amylin receptor and GLP-1 receptor agonists reduced food intake and body weight synergistic-like, its influence on alcohol intake is unknown.

Experimental approach: Effects of a range of dose-combinations of GLP-1 receptor (dulaglutide) and amylin receptor (salmon calcitonin; sCT) agonists on alcohol intake were explored in male and female rats. We used dose combinations that either lowered alcohol intake as monotherapy (0.1 mg·kg-1 + 5 μg·kg-1), or that did not affect alcohol consumption per se (0.075 mg·kg-1 + 2 μg·kg-1).

Key results: Acute administration of dulaglutide and sCT (0.1 mg·kg-1 + 5 μg·kg-1) reduced alcohol intake in males, but not in females. When higher doses were evaluated in female rats, a decrease in alcohol intake was observed. Furthermore, the low dose combination (0.075 mg·kg-1 + 2 μg·kg-1) decreased, in in a synergistic-like manner, alcohol intake and prevented abstinence-induced drinking without affecting kaolin intake in males. However, tolerance developed during sub-chronic treatment.

Conclusion and implications: Collectively, these findings show that the combination of dulaglutide and sCT decreased, in in a synergistic-like manner, alcohol consumption in male rats. Contrarily, higher doses are required for females.

Keywords: GLP‐1; alcohol use disorder; amylin; dopamine; gut–brain axis; reward.

PubMed Disclaimer

References

REFERENCES

    1. Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Davies, J. A., Abbracchio, M. P., Abraham, G., Agoulnik, A., Alexander, W., Al‐Hosaini, K., Bäck, M., Baker, J. G., Barnes, N. M., … Ye, R. D. (2023). The Concise Guide to PHARMACOLOGY 2023/24: G protein‐coupled receptors. British Journal of Pharmacology, 180(Suppl 2), S23–S144. https://doi.org/10.1111/bph.16177
    1. Aranäs, C., Blid Sköldheden, S., & Jerlhag, E. (2023). Antismoking agents do not contribute synergistically to semaglutide's ability to reduce alcohol intake in rats. Frontiers in Pharmacology, 14, 1180512.
    1. Aranäs, C., Edvardsson, C. E., Shevchouk, O. T., Zhang, Q., Witley, S., Blid Sköldheden, S., Zentveld, L., Vallöf, D., Tufvesson‐Alm, M., & Jerlhag, E. (2023). Semaglutide reduces alcohol intake and relapse‐like drinking in male and female rats. eBioMedicine, 93, 104642.
    1. Aranäs, C., Vestlund, J., Witley, S., Edvardsson, C. E., Kalafateli, A. L., & Jerlhag, E. (2021). Salmon calcitonin attenuates some behavioural responses to nicotine in male mice. Frontiers in Pharmacology, 12, 685631.
    1. Bello, N. T., Kemm, M. H., Ofeldt, E. M., & Moran, T. H. (2010). Dose combinations of exendin‐4 and salmon calcitonin produce additive and synergistic reductions in food intake in non‐human primates. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 299(3), R945–R952.

MeSH terms

LinkOut - more resources